Clin2
NCT07240675Likely a fitRecruiting

First-in-human safety study of KLA478 in healthy volunteers

Healthy Volunteers

This study tests a new drug called KLA478 for the first time in humans. It is looking for healthy volunteers to see how the drug affects the body and how safe it is.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
40 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • Be a healthy adult between 18 and 45 years old
  • Weigh at least 50 kg for men or 45 kg for women, with a body mass index between 19 and 28
  • Have normal or near-normal health check results
  • Agree to use birth control for 3 to 6 months after the study
  • Be willing to avoid smoking, alcohol, certain foods, and other medications during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07522970Recruiting· Phase 1
Safety and Tolerability Study of LG-0317 in Healthy Adults

This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.

Shanghai, Shanghai Municipality
NCT07143318Recruiting· Phase 1
First-in-Human study of KLA578-1 for injection in healthy volunteers

This trial tests a new investigational drug for the first time in people. It will study how the drug is processed by the body in healthy volunteers. If you are a generally healthy adult, you may be able to help with this important early research.

Changsha, Hunan
NCT07474545Recruiting· Phase 1
Safety study of KL0011034 injection in healthy volunteers

This trial tests a new injection called KL0011034 to see if it is safe and how the body processes it. Healthy volunteers aged 18–45 who meet specific health and lifestyle criteria can join.

Changsha, Hunan
NCT07429006Recruiting· Phase 1
First human trial of AKB-9090 in healthy adults

This study is testing a new medication called AKB-9090 for the first time in people. It will help find out how the drug works in the body and how safe it is. The study is looking for healthy volunteers.

Auckland
NCT07030790Recruiting· Phase 1
Single dose study of KLA480 in healthy volunteers

This trial tests a single dose of KLA480 in healthy adults to see how the body processes it. It may help researchers understand the drug's safety and potential benefits.

Shanghai, Shanghai Municipality
NCT07409922Recruiting· Phase 1
Testing KR23343 in healthy volunteers

This study tests a new medicine, KR23343, in healthy adults to see how the body handles it at different doses. It helps find the right dose and check for any early side effects.

Shanghai

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.